Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology.

导出原文传递

翻译打印收藏纠错

作者： Outi,Uimari ^[1] ; Anne,Ahtikoski ^[2] ; Kati,Kämpjärvi ^[3] ; Ralf,Butzow ^[4] ; Ilkka Y,Järvelä ^[5] ; Markku,Ryynänen ^[6] ; Lauri A,Aaltonen ^[7] ; Pia,Vahteristo ^[8] ; Outi,Kuismin ^[9]

作者单位： Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland. ^[1] PEDEGO Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland. ^[2] Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland. ^[3] Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland. ^[4] Department of Pathology, Turku University Hospital and University of Turku, Turku, Finland. ^[5] Research Programs Unit, Applied Tumor Genomics, University of Helsinki, Helsinki, Finland. ^[6] Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. ^[7] Department of Pathology, The Laboratory of Helsinki University Central Hospital (HUSLAB), Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. ^[8] Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland. ^[9] Department of Clinical Genetics, Oulu University Hospital, Oulu, Finland. ^[10]

关键词 Bcl-2 CD34 HLRCC fumarate hydratase hereditary leiomyomatosis and renal cell cancer uterine leiomyoma